Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 20, 2019
CherryCircle announced the appointment of Emma Cartmell to its board of directors.
read more
Wednesday, March 20, 2019
NJII has signed an Industry Participation Agreement with Pall Corporation to support the development of its BioPharmaceutical Innovation iLab.
read more
Wednesday, March 20, 2019
Pulse Biosciences announced the appointment of Mitchell Levinson to its board of directors.
read more
Wednesday, March 20, 2019
Merck and NGM announced Merck has exercised its option to extend the research phase of the companies’ collaboration for an additional two-year period to March 2022.
read more
Wednesday, March 20, 2019
Merck KGaA, Darmstadt, Germany and Pfizer announced the discontinuation of the ongoing Phase III JAVELIN Ovarian PARP 100 study evaluating avelumab in combination with chemotherapy.
read more
C2 PHARMA has acquired the Digoxin API product portfolio of Polish company, Nobilus Ent, self-developed and inherited from Roche/Galenus Mannheim.
read more
Alcami has launched Alcami Biologics, the organization's new biopharmaceutical development, analytical testing, manufacturing, and packaging enterprise.
read more
Under a license agreement with the HMRI for development of clinical grade RNA manufacturing services, VGXI announced it has completed all of the partnership’s Phase I initiatives and anticipates Phase II will conclude by 4Q 2019.
read more
Novartis has announced Richard Francis will be stepping down as CEO of Sandoz, a Novartis division, and as a member of the Executive Committee of Novartis on March 31, 2019.
read more
Under this co-exclusive agreement, the Pall Biotech line of business will immediately distribute ARTeSYN's standard hardware and liner components off the shelf.
read more
SunGen Pharma announced the launch of Busulfan Injection, the second product launch through their joint venture Peterson Athenex with Athenex Pharmaceuticals.
read more
JSR today it will establish a US headquarters for its biotechnology and life sciences focused businesses under the name JSR Life Sciences, LLC effective April 1, 2019.
read more
BioVectra announced a five-year, $144.6 million (CAD) expansion project to enhance its Biopharmaceutical capabilities in both Charlottetown, Prince Edward Island and Windsor, Nova Scotia.
read more
Piramal Critical Care announced the launch of MITIGO™ (Morphine Sulfate Injection, USP – Preservative-free) in 10 mg/mL and 25 mg/mL concentrations in the U.S. market.
read more
Walgreens Boots Alliance has named Heather Dixon as its new senior vice president, global controller and chief accounting officer, effective March 18, 2019.
read more